Preface |
|
xi | |
Contributors |
|
xiii | |
|
1 Introduction to pharmacology |
|
|
1 | (8) |
|
|
1 | (2) |
|
|
3 | (3) |
|
|
6 | (3) |
|
2 The prescription and drug names |
|
|
9 | (14) |
|
I Parts of a prescription |
|
|
9 | (1) |
|
|
10 | (1) |
|
|
11 | (2) |
|
IV Principles of prescription writing |
|
|
13 | (6) |
|
V How to avoid prescription errors |
|
|
19 | (4) |
|
|
23 | (18) |
|
I Basic principles of drug dosing |
|
|
23 | (3) |
|
|
26 | (5) |
|
a Penicillin VK oral suspension |
|
|
27 | (1) |
|
b How is the dose calculated if the child could swallow tablets? |
|
|
27 | (1) |
|
|
27 | (1) |
|
c If amoxicillin were to be prescribed |
|
|
28 | (1) |
|
Amoxicillin oral suspension |
|
|
28 | (1) |
|
Amoxicillin chewable tablets |
|
|
28 | (1) |
|
|
29 | (1) |
|
|
30 | (1) |
|
|
30 | (1) |
|
|
30 | (1) |
|
|
30 | (1) |
|
Clindamycin oral solution |
|
|
30 | (1) |
|
|
30 | (1) |
|
III Pregnant and nursing patients |
|
|
31 | (4) |
|
|
35 | (1) |
|
|
35 | (2) |
|
VI Hepatic-impaired patient |
|
|
37 | (4) |
|
|
41 | (64) |
|
I Antitnicrobials, systemic |
|
|
41 | (18) |
|
|
41 | (4) |
|
|
45 | (1) |
|
|
45 | (3) |
|
|
48 | (1) |
|
|
49 | (3) |
|
|
52 | (1) |
|
|
53 | (1) |
|
|
54 | (2) |
|
|
56 | (2) |
|
c Specific instructions for taking antibiotics |
|
|
58 | (1) |
|
II Antitnicrobials, local |
|
|
59 | (5) |
|
a Controlled-release drug delivery |
|
|
59 | (4) |
|
b Other mouthrinses and periodontal health products |
|
|
63 | (1) |
|
III Controlled-release drug delivery |
|
|
64 | (1) |
|
IV Antivirals/antifungal agents |
|
|
65 | (7) |
|
|
65 | (3) |
|
|
68 | (4) |
|
V Prescribing for pain control |
|
|
72 | (22) |
|
|
72 | (1) |
|
|
72 | (2) |
|
c Nonsteroidal anti-inflammatory drugs (NSAIDs) |
|
|
74 | (6) |
|
|
80 | (3) |
|
e Narcotic (opioid) analgesics |
|
|
83 | (7) |
|
f Management plan for acute dental pain |
|
|
90 | (4) |
|
|
94 | (3) |
|
|
95 | (1) |
|
|
96 | (1) |
|
|
97 | (8) |
|
a Topical Glucocorticosteroids |
|
|
97 | (3) |
|
b Other nonsteroidal topical agents used in the management of oral lesions |
|
|
100 | (1) |
|
c Systemic corticosteroids |
|
|
100 | (5) |
|
5 How to manage potential drug interactions |
|
|
105 | (20) |
|
I Introduction to drug interactions |
|
|
105 | (5) |
|
II Antibiotic-drug interactions in dentistry |
|
|
110 | (6) |
|
III Analgesic-drug interactions in dentistry |
|
|
116 | (3) |
|
IV Sympathomimetic agents and drug interactions in dentistry |
|
|
119 | (3) |
|
V Anti-anxiety drug interactions in dentistry |
|
|
122 | (3) |
|
6 Evidence-based theory for drug prescribing |
|
|
125 | (24) |
|
|
125 | (2) |
|
II Prescribing for inflammatory periodontal diseases and periodontal surgical procedures |
|
|
127 | (8) |
|
|
127 | (1) |
|
|
127 | (2) |
|
c Ulcerative periodontal diseases |
|
|
129 | (1) |
|
d Refractory and recurrent periodontitis |
|
|
130 | (1) |
|
e Aggressive periodontitis |
|
|
131 | (1) |
|
|
132 | (1) |
|
Periodontal flap surgery: pocket reduction |
|
|
132 | (1) |
|
Bone/bone substitutes grafting procedures |
|
|
133 | (1) |
|
Periodontal regenerative surgery: Guided tissue regeneration (GTR) |
|
|
134 | (1) |
|
III Prescribing for dental implant surgery |
|
|
135 | (4) |
|
a Prescribing for sinus floor elevation surgery |
|
|
136 | (3) |
|
IV Prescribing for oral surgery |
|
|
139 | (1) |
|
V Prescribing for odontogenic infections |
|
|
139 | (10) |
|
a Prescribing for endodontic abscess |
|
|
140 | (5) |
|
b Prescribing for periodontal abscess |
|
|
145 | (4) |
|
7 Management of the medically compromised dental patient |
|
|
149 | (56) |
|
I American Heart Association (AHA) guidelines for antibiotic prophylaxis |
|
|
149 | (3) |
|
a Prevention of infective endocarditis: Antibiotic prophylaxis for the dental patient |
|
|
149 | (3) |
|
II Antibiotic prophylaxis for total joint replacement |
|
|
152 | (3) |
|
III Cardiovascular diseases |
|
|
155 | (19) |
|
|
155 | (7) |
|
b Angina and other ischemic cardiac conditions |
|
|
162 | (1) |
|
c Congestive heart failure |
|
|
163 | (1) |
|
d Patient on low-dose aspirin and other antiplatelet drugs |
|
|
163 | (5) |
|
e Anticoagulated patient (patient taking warfarin or heparin) |
|
|
168 | (3) |
|
f Low-molecular-weight heparins (LMWHs) |
|
|
171 | (1) |
|
|
171 | (1) |
|
|
172 | (1) |
|
|
172 | (2) |
|
IV Pregnant and postpartum patient |
|
|
174 | (1) |
|
V Adrenal suppression and thyroid disease |
|
|
175 | (1) |
|
|
176 | (2) |
|
|
178 | (2) |
|
VIII Psychiatric/neurological disorders |
|
|
180 | (1) |
|
|
181 | (5) |
|
|
186 | (1) |
|
XI Chronic kidney disease |
|
|
187 | (2) |
|
XII Recreational and illicit drugs |
|
|
189 | (2) |
|
|
191 | (6) |
|
|
197 | (1) |
|
|
198 | (2) |
|
|
200 | (5) |
|
8 Herbal and natural remedies |
|
|
205 | (4) |
|
I Herbal-drug interactions |
|
|
205 | (1) |
|
II Implications in dentistry |
|
|
206 | (3) |
|
Appendix 1 Smoking cessation therapy |
|
|
209 | (6) |
|
Appendix 2 Oral manifestation of drugs |
|
|
215 | (4) |
|
Appendix 3 American Heart Association antibiotic prophylaxis guidelines |
|
|
219 | (2) |
|
Appendix 4 List of tables |
|
|
221 | (2) |
|
Appendix 5 Pharmacology pearls in dental practice |
|
|
223 | (2) |
|
Appendix 6 Dental drug formulary |
|
|
225 | (2) |
|
|
225 | (1) |
|
|
225 | (1) |
|
|
225 | (1) |
|
|
225 | (1) |
|
|
225 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
|
|
226 | (1) |
Index |
|
227 | |